iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Price Up 1.5% – Still a Buy?

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) rose 1.5% during trading on Tuesday . The company traded as high as $31.45 and last traded at $31.17. 20,361 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 38,904 shares. The stock had previously closed at $30.70.

iShares Genomics Immunology and Healthcare ETF Trading Up 1.8%

The firm has a 50-day simple moving average of $29.85 and a two-hundred day simple moving average of $28.98. The company has a market capitalization of $175.98 million, a price-to-earnings ratio of 14.76 and a beta of 0.96.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

A hedge fund recently raised its stake in iShares Genomics Immunology and Healthcare ETF stock. Ameriprise Financial Inc. boosted its holdings in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 8.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 71,473 shares of the company’s stock after acquiring an additional 5,540 shares during the quarter. Ameriprise Financial Inc. owned approximately 1.42% of iShares Genomics Immunology and Healthcare ETF worth $1,688,000 at the end of the most recent reporting period.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.